Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription

Articles published in Ann Hematol

Retrieve available abstracts of 138 articles:
HTML format

Single Articles

    November 2021
  1. VIVES-CORRONS JL, Krishnevskaya E, Hernandez-Rodriguez I, Payan-Pernia S, et al
    Red cell ektacytometry in two patients with chronic hemolytic anemia and three new alpha-spectrin variants.
    Ann Hematol. 2021 Nov 29. pii: 10.1007/s00277-021-04723.
    PubMed     Abstract available

  2. JIANG Z, Jiang X, Chen M
    Severe aplastic anemia in a patient with erythropoietic protoporphyria successfully treated by avatrombopag.
    Ann Hematol. 2021 Nov 26. pii: 10.1007/s00277-021-04726.

  3. MATSUYAMA Y, Hosoi H, Horitani R, Kawamoto S, et al
    Management of warm autoimmune hemolytic anemia related to band 3-positive colon carcinoma.
    Ann Hematol. 2021 Nov 5. pii: 10.1007/s00277-021-04714.

  4. DUCA L, Nava I, Tavazzi D, Marcon A, et al
    Epidemiological shift of glucose-6-phosphate dehydrogenase mutations in northern Italy in the last 15 years.
    Ann Hematol. 2021;100:2683-2688.
    PubMed     Abstract available

  5. KULAGIN AD, Ptushkin VV, Lukina EA, Davydkin IL, et al
    Randomized multicenter noninferiority phase III clinical trial of the first biosimilar of eculizumab.
    Ann Hematol. 2021;100:2689-2698.
    PubMed     Abstract available

    October 2021
  6. EL FAKIH R, Alfraih F, Alhayli S, Ahmed SO, et al
    Frontline-matched sibling donor transplant of aplastic anemia patients using primed versus steady-state bone marrow grafts.
    Ann Hematol. 2021 Oct 31. pii: 10.1007/s00277-021-04708.
    PubMed     Abstract available

  7. BIASSI TP, Guerra-Shinohara EM, Moretti PNS, de Freitas Dutra V, et al
    miRNA profile and disease severity in patients with sickle cell anemia.
    Ann Hematol. 2021 Oct 22. pii: 10.1007/s00277-021-04665.
    PubMed     Abstract available

  8. PEREIRA-MARTINS DA, Coelho-Silva JL, Domingos IF, Weinhauser I, et al
    The ratio of ATP11C/PLSCR1 mRNA transcripts has clinical significance in sickle cell anemia.
    Ann Hematol. 2021 Oct 14. pii: 10.1007/s00277-021-04696.
    PubMed     Abstract available

  9. SHOKRGOZAR N, Karimi M, Golmoghaddam H, Rezaei N, et al
    Expression of the immune checkpoint receptors CTLA-4, LAG-3, and TIM-3 in beta-thalassemia major patients: correlation with alloantibody production and regulatory T cells (Tregs) phenotype.
    Ann Hematol. 2021;100:2463-2469.
    PubMed     Abstract available

  10. ABDULHAI F, Jaffa MA, Elias J, Zakka P, et al
    Digital thermography and vascular involvement in beta-thalassemia intermedia.
    Ann Hematol. 2021;100:2471-2477.
    PubMed     Abstract available

    September 2021
  11. HIRAMOTO N, Yamazaki H, Nakamura Y, Uchida N, et al
    Total body irradiation-containing conditioning regimens without antithymocyte globulin in adults with aplastic anemia undergoing umbilical cord blood transplantation.
    Ann Hematol. 2021 Sep 21. pii: 10.1007/s00277-021-04664.
    PubMed     Abstract available

  12. THONG EWS, Tan SS, Sethi SK, Chee YL, et al
    Falsely elevated serum vitamin B12 levels in a case of pernicious anemia.
    Ann Hematol. 2021 Sep 10. pii: 10.1007/s00277-021-04612.

  13. WOUTERS HJCM, Conrads-Frank A, Koinig KA, Smith A, et al
    The anemia-independent impact of myelodysplastic syndromes on health-related quality of life.
    Ann Hematol. 2021 Sep 2. pii: 10.1007/s00277-021-04654.
    PubMed     Abstract available

  14. JANG T, Mo G, Stewart C, Khoury L, et al
    Obesity and diabetes mellitus in patients with sickle cell disease.
    Ann Hematol. 2021;100:2203-2205.
    PubMed     Abstract available

  15. BOGA C, Asma S, Leblebisatan G, Sen N, et al
    Comparison of the clinical course of COVID-19 infection in sickle cell disease patients with healthcare professionals.
    Ann Hematol. 2021;100:2195-2202.
    PubMed     Abstract available

    August 2021
  16. CHENOU F, Hounkpe BW, Domingos IF, Tonasse WV, et al
    Effect of hydroxyurea therapy on intravascular hemolysis and endothelial dysfunction markers in sickle cell anemia patients.
    Ann Hematol. 2021 Aug 28. pii: 10.1007/s00277-021-04636.
    PubMed     Abstract available

  17. YAMADA S, Kajikawa S, Nakagawa N, Kondo Y, et al
    Coombs' test positive autoimmune hemolytic anemia accompanied by myelodysplastic syndrome that became Coombs' test negative after azacitidine administration.
    Ann Hematol. 2021 Aug 27. pii: 10.1007/s00277-021-04652.

  18. ATIPIMONPAT A, Siwaponanan P, Khuhapinant A, Svasti S, et al
    Extracellular vesicles from thalassemia patients carry iron-containing ferritin and hemichrome that promote cardiac cell proliferation.
    Ann Hematol. 2021;100:1929-1946.
    PubMed     Abstract available

  19. TRANEKAER S, Hansen DL, Biemond BJ, Sorensen AL, et al
    Priapism in patients with hemolytic disorders: a nationwide retrospective cohort study.
    Ann Hematol. 2021;100:1947-1951.
    PubMed     Abstract available

  20. SINGHA K, Fucharoen G, Fucharoen S
    delta-Hemoglobinopathies in Thailand: screening, molecular basis, genotype-phenotype interaction, and implication for prevention and control of thalassemia.
    Ann Hematol. 2021;100:1953-1963.
    PubMed     Abstract available

  21. HOSOKAWA K, Ishiyama K, Ikemoto T, Sugimori C, et al
    The clinical significance of PNH-phenotype cells accounting for < 0.01% of total granulocytes detected by the Clinical and Laboratory Standards Institute methods in patients with bone marrow failure.
    Ann Hematol. 2021;100:1975-1982.
    PubMed     Abstract available

    July 2021
  22. NORASETTHADA L, Wongkhantee S, Chaipokam J, Charoenprasert K, et al
    Adult aplastic anemia in Thailand: incidence and treatment outcome from a prospective nationwide population-based study.
    Ann Hematol. 2021 Jul 16. pii: 10.1007/s00277-021-04566.
    PubMed     Abstract available

  23. YANG W, Zhao X, Peng G, Zhang L, et al
    Time and residual hematopoiesis are crucial for PNH clones escape in hepatitis-associated aplastic anemia.
    Ann Hematol. 2021 Jul 16. pii: 10.1007/s00277-021-04553.
    PubMed     Abstract available

  24. CAO J, Pei R, Zhang P, Liu X, et al
    Successful haploidentical transplantation using plasma exchange and post-transplantation cyclophosphamide for severe aplastic anemia patients with anti-human leukocyte antigen donor-specific antibodies.
    Ann Hematol. 2021 Jul 6. pii: 10.1007/s00277-021-04497.
    PubMed     Abstract available

  25. GOREN SAHIN D, Akay OM, Keklik M, Okan V, et al
    Clinical characteristics and therapeutic outcomes of paroxysmal nocturnal hemoglobinuria patients in Turkey: a multicenter experience.
    Ann Hematol. 2021;100:1667-1675.
    PubMed     Abstract available

  26. ELZAEEM DI, Sharkawi EAE, Zaki EM, Ghobrial AG, et al
    Comparative study of IgG binding to megakaryocytes in immune and myelodysplastic thrombocytopenic patients.
    Ann Hematol. 2021;100:1701-1709.
    PubMed     Abstract available

  27. NJUE L, Medri C, Keller P, Diepold M, et al
    The rare hemoglobin variant Hb Mizuho: report of a Swiss family and literature review.
    Ann Hematol. 2021;100:1677-1683.
    PubMed     Abstract available

    June 2021
  28. BATISTA JVGF, Pereira-Martins DA, Falcao DA, Domingos IF, et al
    Association of KLOTHO polymorphisms with clinical complications of sickle cell anemia.
    Ann Hematol. 2021 Jun 14. pii: 10.1007/s00277-021-04532.
    PubMed     Abstract available

  29. KRECAK I, Cengic M, Skoric I, Nakic M, et al
    Concomitant autoimmune hemolytic anemia and pure red cell aplasia in a patient with chronic lymphocytic leukemia successfully treated with ibrutinib.
    Ann Hematol. 2021 Jun 10. pii: 10.1007/s00277-021-04570.

  30. AL-TAWFIQ JA, Rabaan AA, AlEdreesi MH
    Frequency of bacteremia in patients with sickle cell disease: a longitudinal study.
    Ann Hematol. 2021;100:1411-1416.
    PubMed     Abstract available

  31. ARPACI A, Gul BU, Ozcan O, Ilhan G, et al
    Presentation of two new mutations in the 3'untranslated region of the beta-globin gene and evaluating the molecular spectrum of thalassemia mutations in the Mediterranean region of Turkey.
    Ann Hematol. 2021;100:1429-1438.
    PubMed     Abstract available

  32. BHURANI D, Kapoor J, Yadav N, Khushoo V, et al
    Experience with combination of hydroxyurea and low-dose thalidomide in transfusion-dependent beta thalassemia patients.
    Ann Hematol. 2021;100:1417-1427.
    PubMed     Abstract available

  33. MAROUF R, Adekile AD, El-Muzaini H, Abdulla R, et al
    Neutrophil gelatinase-associated lipocalin as a biomarker of nephropathy in sickle cell disease.
    Ann Hematol. 2021;100:1401-1409.
    PubMed     Abstract available

    May 2021
  34. HERBRETEAU L, Le Calloch R, Arnaud B, Cassou N, et al
    Eculizumab, a real-life successful treatment for refractory cold agglutinin-mediated auto-immune hemolytic anemia secondary to lymphoproliferative disorders.
    Ann Hematol. 2021 May 18. pii: 10.1007/s00277-021-04557.

  35. QIN X, Zhu YP, Luo CJ, Zhou M, et al
    Optimizing conditioning regimen with low-dose irradiation or busulfan enables the outcome of transplantation from a 6-7/8 HLA-matched donor comparable to that from an 8/8 HLA-matched unrelated donor in severe aplastic anemia patients under 40 years.
    Ann Hematol. 2021 May 14. pii: 10.1007/s00277-021-04540.
    PubMed     Abstract available

    Opioids are not a major cause of death of patients with sickle cell disease.
    Ann Hematol. 2021;100:1133-1138.
    PubMed     Abstract available

    April 2021
  37. MENDOZA E, Duque X, Moran S, Martinez-Andrade G, et al
    Hepcidin and other indicators of iron status, by alpha-1 acid glycoprotein levels, in a cohort of Mexican infants.
    Ann Hematol. 2021;100:879-890.
    PubMed     Abstract available

  38. RAMSAY Z, Gabbadon CH, Asnani M
    Numb chin syndrome in sickle cell disease: a case series of Jamaican patients.
    Ann Hematol. 2021;100:913-919.
    PubMed     Abstract available

  39. HATAIRAKTHAM S, Masaratana P, Hantaweepant C, Srisawat C, et al
    Curcuminoids supplementation ameliorates iron overload, oxidative stress, hypercoagulability, and inflammation in non-transfusion-dependent beta-thalassemia/Hb E patients.
    Ann Hematol. 2021;100:891-901.
    PubMed     Abstract available

    March 2021
  40. YOUSSEF JG, Zahiruddin F, Youssef G, Padmanabhan S, et al
    G6PD deficiency and severity of COVID19 pneumonia and acute respiratory distress syndrome: tip of the iceberg?
    Ann Hematol. 2021;100:667-673.
    PubMed     Abstract available

  41. SAEIDNIA M, Nowrouzi-Sohrabi P, Erfani M, Fazeli P, et al
    The effect of curcumin on serum copper, zinc, and zinc/copper ratio in patients with beta-thalassemia intermedia: a randomized double-blind clinical trial.
    Ann Hematol. 2021;100:627-633.
    PubMed     Abstract available

  42. VERMA HK, Ratre YK, Bhaskar LVKS, Colombatti R, et al
    Erythrocyte microRNAs: a tiny magic bullet with great potential for sickle cell disease therapy.
    Ann Hematol. 2021;100:607-614.
    PubMed     Abstract available

  43. HAGHPANAH S, Cohan N, Bordbar M, Bazrafshan A, et al
    Effects of three months of treatment with vitamin E and N-acetyl cysteine on the oxidative balance in patients with transfusion-dependent beta-thalassemia.
    Ann Hematol. 2021;100:635-644.
    PubMed     Abstract available

  44. SCHULLER H, Klein F, Lubbert M, Prager EP, et al
    Hemolytic crisis in a patient treated with eculizumab for paroxysmal nocturnal hemoglobinuria possibly triggered by SARS-CoV-2 (COVID-19): a case report.
    Ann Hematol. 2021;100:841-842.

  45. MISTRY RH, Kohut A, Ford P
    Correction of iron deficiency in hospitalized heart failure patients does not improve patient outcomes.
    Ann Hematol. 2021;100:661-666.
    PubMed     Abstract available

    February 2021
  46. HSIEH TC, Sostin O
    Severe warm autoimmune hemolytic anemia in COVID-19 managed with least incompatible RBC product and glucocorticoids.
    Ann Hematol. 2021 Feb 18. pii: 10.1007/s00277-021-04457.

  47. HATZLHOFER BLD, Pereira-Martins DA, de Farias Domingos I, Arcanjo GDS, et al
    Alpha thalassemia, but not beta(S)-globin haplotypes, influence sickle cell anemia clinical outcome in a large, single-center Brazilian cohort.
    Ann Hematol. 2021 Feb 13. pii: 10.1007/s00277-021-04450.
    PubMed     Abstract available

  48. LADEIRA VS, Barbosa AR, Oliveira MM, Ferreira LGR, et al
    ADAMTS-13-VWF axis in sickle cell disease patients.
    Ann Hematol. 2021;100:375-382.
    PubMed     Abstract available

  49. KUMAR R, Yadav R, Mishra S, Singh MPSS, et al
    Kruppel-like factor 1 (KLF1) gene single nucleotide polymorphisms in sickle cell disease and its association with disease-related morbidities.
    Ann Hematol. 2021;100:365-373.
    PubMed     Abstract available

  50. BATISTA JVGF, Arcanjo GS, Batista THC, Sobreira MJ, et al
    Influence of UGT1A1 promoter polymorphism, alpha-thalassemia and beta(s) haplotype in bilirubin levels and cholelithiasis in a large sickle cell anemia cohort.
    Ann Hematol. 2021 Feb 1. pii: 10.1007/s00277-021-04422.
    PubMed     Abstract available

    January 2021
  51. MARTYNOVA A, Chiu V, Mert M, Hermel D, et al
    Effectiveness and safety of tacrolimus with or without eltrombopag, as a part of immunosuppressive treatment of aplastic anemia in adults: a retrospective case series.
    Ann Hematol. 2021 Jan 9. pii: 10.1007/s00277-021-04401.
    PubMed     Abstract available

  52. STACY S, Sheth S, Coleman B, Cerenzia W, et al
    An assessment of the continuing medical education needs of US physicians in the management of patients with beta thalassemia.
    Ann Hematol. 2021;100:27-35.
    PubMed     Abstract available

    December 2020
  53. GIORDANO G, Napolitano M, Di Battista V, Lucchesi A, et al
    Oral high-dose sucrosomial iron vs intravenous iron in sideropenic anemia patients intolerant/refractory to iron sulfate: a multicentric randomized study.
    Ann Hematol. 2020 Dec 2. pii: 10.1007/s00277-020-04361.
    PubMed     Abstract available

  54. WU Y, Yao Q, Zhong M, Wu J, et al
    Genetic research and clinical analysis of deletional Chinese (G)gamma(+)((A)gammadeltabeta)(0) -thalassemia and Southeast Asian HPFH in South China.
    Ann Hematol. 2020;99:2747-2753.
    PubMed     Abstract available

  55. SINHA S, Jit BP, Patro ARK, Ray A, et al
    Influence of rs1042713 and rs1042714 polymorphisms of beta2-adrenergic receptor gene with erythrocyte cAMP in sickle cell disease patients from Odisha State, India.
    Ann Hematol. 2020;99:2737-2745.
    PubMed     Abstract available

  56. PAZGAL I, Yahalom V, Shalev B, Raanani P, et al
    Alloimmunization and autoimmunization in adult transfusion-dependent thalassemia patients: a report from a comprehensive center in Israel.
    Ann Hematol. 2020;99:2731-2736.
    PubMed     Abstract available

    November 2020
  57. MENDEZ M, Moreno-Carralero MI, Peri VL, Camacho-Galan R, et al
    Congenital dyserythropoietic anemia types Ib, II, and III: novel variants in the CDIN1 gene and functional study of a novel variant in the KIF23 gene.
    Ann Hematol. 2020 Nov 7. pii: 10.1007/s00277-020-04319.
    PubMed     Abstract available

  58. RUAN J, Zuo W, Chen M, Yang C, et al
    Correction to: Eltrombopag is effective in patients with relapse/refractory aplastic anemia-report from a single center in China.
    Ann Hematol. 2020 Nov 2. pii: 10.1007/s00277-020-04301.
    PubMed     Abstract available

  59. ABDULLAH N, Ismail N, Abd Jalal N, Mohd Radin F, et al
    Prevalence of anaemia and associated risk factors amongst The Malaysian Cohort participants.
    Ann Hematol. 2020;99:2521-2527.
    PubMed     Abstract available

  60. DESAI RJ, Mahesri M, Globe D, Mutebi A, et al
    Clinical outcomes and healthcare utilization in patients with sickle cell disease: a nationwide cohort study of Medicaid beneficiaries.
    Ann Hematol. 2020;99:2497-2505.
    PubMed     Abstract available

  61. BALLAS SK, Dampier C
    Risk factors associated with increased emergency department utilization in patients with sickle cell disease: a systematic literature review.
    Ann Hematol. 2020;99:2483-2495.
    PubMed     Abstract available

  62. KIRITO K
    Expansion of paroxysmal nocturnal hemoglobinuria clones in MPLW515L mutation harboring primary myelofibrosis.
    Ann Hematol. 2020;99:2707-2709.

  63. TRIPATHI P, Agarwal S, Gupta A, Mandal K, et al
    Biallelic rare 17 bp deletion mutation (HBB:c.380_396 del TGCAGGCTGCCTATCAG) in a transfusion depended form of thalassemia.
    Ann Hematol. 2020;99:2719-2722.

    October 2020
  64. WAN K, Yin Y, Luo Z, Cheng J, et al
    Correction to: Remarkable response to roxadustat in a case of anti-erythropoietin antibody-mediated pure red cell aplasia.
    Ann Hematol. 2020 Oct 16. pii: 10.1007/s00277-020-04300.
    PubMed     Abstract available

  65. ONISHI Y, Mori T, Yamazaki H, Takenaka K, et al
    Cyclosporine/methotrexate versus tacrolimus/methotrexate with or without anti-thymocyte globulin as GVHD prophylaxis in adult patients with aplastic anemia.
    Ann Hematol. 2020 Oct 9. pii: 10.1007/s00277-020-04290.
    PubMed     Abstract available

  66. LAN Y, Chang L, Yi M, Cai Y, et al
    Long-term outcomes of 172 children with severe aplastic anemia treated with rabbit antithymocyte globulin and cyclosporine.
    Ann Hematol. 2020 Oct 8. pii: 10.1007/s00277-020-04296.
    PubMed     Abstract available

  67. ONISHI Y, Yokoyama H, Katsuoka Y, Ito T, et al
    Low-dose lenalidomide and dexamethasone therapy after melphalan-prednisolone induction in elderly patients with newly diagnosed multiple myeloma.
    Ann Hematol. 2020;99:2351-2356.
    PubMed     Abstract available

  68. FUREDER W, Sperr WR, Heibl S, Zebisch A, et al
    Prognostic factors and follow-up parameters in patients with paroxysmal nocturnal hemoglobinuria (PNH): experience of the Austrian PNH network.
    Ann Hematol. 2020;99:2303-2313.
    PubMed     Abstract available

  69. BUTTARI B, Profumo E, Caprari P, Massimi S, et al
    Phenotypical and functional abnormalities of circulating neutrophils in patients with beta-thalassemia.
    Ann Hematol. 2020;99:2265-2277.
    PubMed     Abstract available

  70. EL-GHAMRAWY M, Yassa ME, Tousson AMS, El-Hady MA, et al
    Association between BCL11A, HSB1L-MYB, and XmnI gammaG-158 (C/T) gene polymorphism and hemoglobin F level in Egyptian sickle cell disease patients.
    Ann Hematol. 2020;99:2279-2288.
    PubMed     Abstract available

  71. CHUANG TY, Li JP, Weng TF, Wu KH, et al
    Combined chelation with high-dose deferiprone and deferoxamine to improve survival and restore cardiac function effectively in patients with transfusion-dependent thalassemia presenting severe cardiac complications.
    Ann Hematol. 2020;99:2289-2294.
    PubMed     Abstract available

  72. FRIEDRICH C, Gay J, Alary AS, Arlet JB, et al
    Battle of the clones: paroxysmal nocturnal hemoglobinuria vs myelodysplastic syndrome.
    Ann Hematol. 2020;99:2459-2461.

    September 2020
  73. DREXLER B, Zurbriggen F, Diesch T, Viollier R, et al
    Very long-term follow-up of aplastic anemia treated with immunosuppressive therapy or allogeneic hematopoietic cell transplantation.
    Ann Hematol. 2020 Sep 19. pii: 10.1007/s00277-020-04271.
    PubMed     Abstract available

  74. WAN K, Yin Y, Luo Z, Cheng J, et al
    Remarkable response to roxadustat in a case of anti-erythropoietin antibody-mediated pure red cell aplasia.
    Ann Hematol. 2020 Sep 17. pii: 10.1007/s00277-020-04269.

  75. RUAN J, Zuo W, Chen M, Yang C, et al
    Eltrombopag is effective in patients with relapse/refractory aplastic anemia-report from a single center in China.
    Ann Hematol. 2020 Sep 17. pii: 10.1007/s00277-020-04266.
    PubMed     Abstract available

  76. ASLEH M, Levitas A, Daniel S, Abu-Quider A, et al
    Hepatic and cardiac iron load as determined by MRI T2* in patients with congenital dyserythropoietic anemia type I.
    Ann Hematol. 2020 Sep 12. pii: 10.1007/s00277-020-04263.
    PubMed     Abstract available

  77. ALGASSIM AA, Elghazaly AA, Alnahdi AS, Mohammed-Rahim OM, et al
    Prognostic significance of hemoglobin level and autoimmune hemolytic anemia in SARS-CoV-2 infection.
    Ann Hematol. 2020 Sep 12. pii: 10.1007/s00277-020-04256.
    PubMed     Abstract available

  78. GIANESIN B, Pinto VM, Casale M, Corti P, et al
    Manual erythroexchange in sickle cell disease: multicenter validation of a protocol predictive of volume to exchange and hemoglobin values.
    Ann Hematol. 2020;99:2047-2055.
    PubMed     Abstract available

  79. SHRESTHA O, Khadwal AR, Singhal M, Trehan A, et al
    A high frequency of Gilbert syndrome (UGT1A1*28/*28) and associated hyperbilirubinemia but not cholelithiasis in adolescent and adult north Indian patients with transfusion-dependent beta-thalassemia.
    Ann Hematol. 2020;99:2019-2026.
    PubMed     Abstract available

  80. SALIBA AN, Atoui A, Labban M, Hamade H, et al
    Thalassemia in the emergency department: special considerations for a rare disease.
    Ann Hematol. 2020;99:1967-1977.
    PubMed     Abstract available

  81. BORTOLOTTI M, D'Ambrosio R, Fraquelli M, Pedrotti P, et al
    Liver damage and sickle cell disease: genotype relationship.
    Ann Hematol. 2020;99:2065-2072.
    PubMed     Abstract available

  82. NUALKAEW T, Khamphikham P, Pongpaksupasin P, Kaewsakulthong W, et al
    UNC0638 induces high levels of fetal hemoglobin expression in beta-thalassemia/HbE erythroid progenitor cells.
    Ann Hematol. 2020;99:2027-2036.
    PubMed     Abstract available

  83. DAAR S, Al Khabori M, Al Rahbi S, Hassan M, et al
    Cardiac T2* MR in patients with thalassemia major: a 10-year long-term follow-up.
    Ann Hematol. 2020;99:2009-2017.
    PubMed     Abstract available

  84. RHODES A, Martin S, Wolters P, Rodriguez Y, et al
    Sleep disturbance in adults with sickle cell disease: relationships with executive and psychological functioning.
    Ann Hematol. 2020;99:2057-2064.
    PubMed     Abstract available

  85. DIMITROGLOU Y, Anagnostopoulos F, Aggeli C, Delicou S, et al
    Severity of heart failure and health-related quality of life in beta-thalassemia patients: a cross-sectional study.
    Ann Hematol. 2020;99:2037-2046.
    PubMed     Abstract available

  86. DESAI R, Bansod S, Patel U
    Nationwide prevalence and trends in acute cardiovascular events and in-hospital mortality among adult African Americans with sickle cell trait.
    Ann Hematol. 2020;99:2207-2209.

  87. ANTWI-BOASIAKO C, Andemariam B, Colombatti R, Asare EV, et al
    A study of the geographic distribution and associated risk factors of leg ulcers within an international cohort of sickle cell disease patients: the CASiRe group analysis.
    Ann Hematol. 2020;99:2073-2079.
    PubMed     Abstract available

    August 2020
  88. LONG Z, Li H, Du Y, Chen M, et al
    Gene mutation profile in patients with acquired pure red cell aplasia.
    Ann Hematol. 2020;99:1749-1754.
    PubMed     Abstract available

  89. HUSCENOT T, Galland J, Ouvrat M, Rossignol M, et al
    SARS-CoV-2-associated cold agglutinin disease: a report of two cases.
    Ann Hematol. 2020;99:1943-1944.

  90. LI L, Li Y, Lin L, Yin J, et al
    Outcomes of allogeneic haematopoietic stem cell transplantation for patients with severe aplastic anaemia using the porcine antilymphocyte globulin-containing conditioning regimen.
    Ann Hematol. 2020;99:1863-1871.
    PubMed     Abstract available

  91. LANCMAN G, Marcellino BK, Thibaud S, Troy K, et al
    Coombs-negative hemolytic anemia and elevated plasma hemoglobin levels in COVID-19.
    Ann Hematol. 2020 Aug 1. pii: 10.1007/s00277-020-04202.

    July 2020
  92. SERVATYARI K, Moradveisi B, Yazdanpanah H, Bacigalupo A, et al
    A 30-month-old boy with aplastic anemia caused by electrocution.
    Ann Hematol. 2020 Jul 24. pii: 10.1007/s00277-020-04189.

  93. BETTELLI F, Giusti D, Morselli M, Colaci E, et al
    Epidemiology and clinical outcomes of latent tuberculosis infection in adults affected with acute leukemia or aplastic anemia: a retrospective single-center study.
    Ann Hematol. 2020 Jul 23. pii: 10.1007/s00277-020-04191.

  94. KANG KW, Moon H, Lee BH, Jeon MJ, et al
    Nationwide study of paroxysmal nocturnal hemoglobinuria in South Korea: paradox of eculizumab.
    Ann Hematol. 2020;99:1493-1503.
    PubMed     Abstract available

  95. HARIHARAN P, Kishnani P, Sawant P, Gorivale M, et al
    Genotypic-phenotypic heterogeneity of deltabeta-thalassemia and hereditary persistence of fetal hemoglobin (HPFH) in India.
    Ann Hematol. 2020;99:1475-1483.
    PubMed     Abstract available

  96. CHEN Z, Chen M, Yang C, Han B, et al
    Immunosuppression therapy is effective for both acquired tumor-associated and primary pure red cell aplasia: a match pair case-control study.
    Ann Hematol. 2020;99:1485-1491.
    PubMed     Abstract available

  97. GARCIA-MORIN M, Bardon-Cancho EJ, Belendez C, Zamarro R, et al
    Fifteen years of newborn sickle cell disease screening in Madrid, Spain: an emerging disease in a European country.
    Ann Hematol. 2020;99:1465-1474.
    PubMed     Abstract available

  98. SCHREZENMEIER H, Roth A, Araten DJ, Kanakura Y, et al
    Baseline clinical characteristics and disease burden in patients with paroxysmal nocturnal hemoglobinuria (PNH): updated analysis from the International PNH Registry.
    Ann Hematol. 2020;99:1505-1514.
    PubMed     Abstract available

    June 2020
  99. HUO J, Li X, Shao Y, Ren X, et al
    Long-term follow-up of a novel immunosuppressive strategy of cyclosporine alternatively combined with levamisole for severe aplastic anemia.
    Ann Hematol. 2020 Jun 29. pii: 10.1007/s00277-020-04153.
    PubMed     Abstract available

  100. AMES PRJ, Jeffrey S
    Bortezomib and rituximab in multiply relapsed primary warm autoimmune hemolytic anemia.
    Ann Hematol. 2020 Jun 17. pii: 10.1007/s00277-020-04135.

  101. HOCHMAN MJ, Martin DB
    Coincidence of autoimmune hemolytic anemia and pure red cell aplasia in a patient with CLL.
    Ann Hematol. 2020 Jun 16. pii: 10.1007/s00277-020-04091.

  102. CAPES A, Bailly S, Hantson P, Gerard L, et al
    COVID-19 infection associated with autoimmune hemolytic anemia.
    Ann Hematol. 2020 Jun 16. pii: 10.1007/s00277-020-04137.

  103. KRECAK I, Supe M, Ilic I, Gveric-Krecak V, et al
    Behet-like syndrome associated with aplastic anemia successfully treated with mycophenolate mofetil.
    Ann Hematol. 2020 Jun 13. pii: 10.1007/s00277-020-04119.

  104. GAUT D, Jones J, Chen C, Ghafouri S, et al
    Outcomes related to intravenous fluid administration in sickle cell patients during vaso-occlusive crisis.
    Ann Hematol. 2020;99:1217-1223.
    PubMed     Abstract available

  105. RICCHI P, Meloni A, Costantini S, Spasiano A, et al
    Red blood cell consumption in a large cohort of patients with thalassaemia: a retrospective analysis of main predictors.
    Ann Hematol. 2020;99:1209-1215.
    PubMed     Abstract available

    May 2020
  106. SALES RR, Belisario AR, Faria G, Mendes F, et al
    Functional polymorphisms of BCL11A and HBS1L-MYB genes affect both fetal hemoglobin level and clinical outcomes in a cohort of children with sickle cell anemia.
    Ann Hematol. 2020 May 23. pii: 10.1007/s00277-020-04079.
    PubMed     Abstract available

  107. XU M, Zhao X, Sun F, Zhu R, et al
    A case of iron deficiency anemia with extremely hyperferritinemia responds well to oral iron: the first identified hereditary hyperferritinemia cataract syndrome in China.
    Ann Hematol. 2020 May 20. pii: 10.1007/s00277-020-04085.

  108. JAIN A, Gupta DK
    Daratumumab for refractory warm autoimmune hemolytic anemia.
    Ann Hematol. 2020 May 14. pii: 10.1007/s00277-020-04063.

  109. ALVES AC, da Silva VAL, Dos Santos A, Serra MB, et al
    Sickle cell anemia in the state of Maranhao: a haplotype study.
    Ann Hematol. 2020 May 4. pii: 10.1007/s00277-020-04048.
    PubMed     Abstract available

  110. SVIDNICKI MCCM, Zanetta GK, Congrains-Castillo A, Costa FF, et al
    Targeted next-generation sequencing identified novel mutations associated with hereditary anemias in Brazil.
    Ann Hematol. 2020;99:955-962.
    PubMed     Abstract available

  111. SHAH F, Dwivedi M
    Pathophysiology and recent therapeutic insights of sickle cell disease.
    Ann Hematol. 2020;99:925-935.
    PubMed     Abstract available

    April 2020
  112. MIHAILESCU AM, Musallam KM, Cappellini MD, Taher AT, et al
    Less 'reds' more 'blues': hemoglobin level and depression in non-transfusion-dependent thalassemia.
    Ann Hematol. 2020;99:903-904.

  113. MORE TA, Dongerdiye R, Devendra R, Warang PP, et al
    Mechanosensitive Piezo1 ion channel protein (PIEZO1 gene): update and extended mutation analysis of hereditary xerocytosis in India.
    Ann Hematol. 2020;99:715-727.
    PubMed     Abstract available

  114. AZMAN NF, Abdullah WZ, Hanafi S, Diana R, et al
    Genetic polymorphisms of HbE/beta thalassemia related to clinical presentation: implications for clinical diversity.
    Ann Hematol. 2020;99:729-735.
    PubMed     Abstract available

  115. BEWERSDORF JP, Zeidan AM
    Evolving therapies for lower-risk myelodysplastic syndromes.
    Ann Hematol. 2020;99:677-692.
    PubMed     Abstract available

  116. CHEN Z, Liu X, Chen M, Yang C, et al
    Successful sirolimus treatment of patients with pure red cell aplasia complicated with renal insufficiency.
    Ann Hematol. 2020;99:737-741.
    PubMed     Abstract available

    March 2020
  117. JAMWAL M, Aggarwal A, Sharma P, Bansal D, et al
    Congenital dyserythropoietic anemia type IV with high fetal hemoglobin caused by heterozygous KLF1 p.Glu325Lys: first report in an Indian infant.
    Ann Hematol. 2020 Mar 27. pii: 10.1007/s00277-020-03982.

  118. RENO CO, Barbosa AR, de Carvalho SS, Pinheiro MB, et al
    Oxidative stress assessment in sickle cell anemia patients treated with hydroxyurea.
    Ann Hematol. 2020 Mar 12. pii: 10.1007/s00277-020-03987.
    PubMed     Abstract available

  119. CHEN M, Zhuang J, Yang C, Zhang L, et al
    Rapid response to a single-dose rituximab combined with bortezomib in refractory and relapsed warm autoimmune hemolytic anemia.
    Ann Hematol. 2020 Mar 7. pii: 10.1007/s00277-020-03976.

  120. DOMINGOS IF, Pereira-Martins DA, Sobreira MJVC, Oliveira RTD, et al
    High levels of proinflammatory cytokines IL-6 and IL-8 are associated with a poor clinical outcome in sickle cell anemia.
    Ann Hematol. 2020 Mar 5. pii: 10.1007/s00277-020-03978.
    PubMed     Abstract available

  121. DE LUNA G, Darnige L, Roueff S, Peyrard T, et al
    Usefulness of azacitidine therapy in a sickle cell disease patient with myelodysplastic syndrome.
    Ann Hematol. 2020;99:661-662.

  122. SHOKRGOZAR N, Amirian N, Ranjbaran R, Bazrafshan A, et al
    Evaluation of regulatory T cells frequency and FoxP3/GDF-15 gene expression in beta-thalassemia major patients with and without alloantibody; correlation with serum ferritin and folate levels.
    Ann Hematol. 2020;99:421-429.
    PubMed     Abstract available

  123. LIU X, Lu X, Chen L, Yang Y, et al
    Immunosuppressive therapy for elderly-acquired pure red cell aplasia: cyclosporine A may be more effective.
    Ann Hematol. 2020;99:443-449.
    PubMed     Abstract available

    February 2020
  124. PEFFAULT DE LATOUR R, Huynh L, Ivanova JI, Totev T, et al
    Burden of illness among patients with severe aplastic anemia who have had insufficient response to immunosuppressive therapy: a multicenter retrospective chart review study.
    Ann Hematol. 2020 Feb 17. pii: 10.1007/s00277-019-03809.
    PubMed     Abstract available

  125. NICOLETTI E, Rao G, Bueren JA, Rio P, et al
    Mosaicism in Fanconi anemia: concise review and evaluation of published cases with focus on clinical course of blood count normalization.
    Ann Hematol. 2020 Feb 17. pii: 10.1007/s00277-020-03954.
    PubMed     Abstract available

    January 2020
  126. RUSSO G, Guardabasso V, Romano F, Corti P, et al
    Monitoring oral iron therapy in children with iron deficiency anemia: an observational, prospective, multicenter study of AIEOP patients (Associazione Italiana Emato-Oncologia Pediatrica).
    Ann Hematol. 2020 Jan 21. pii: 10.1007/s00277-020-03906.
    PubMed     Abstract available

  127. EL-GAMAL RAE, Abdel-Messih IY, Habashy DM, Zaiema SEG, et al
    Erythroferrone, the new iron regulator: evaluation of its levels in Egyptian patients with beta thalassemia.
    Ann Hematol. 2020;99:31-39.
    PubMed     Abstract available

    December 2019
  128. QIU Y, Cai H, Cui L, Liu YX, et al
    Identification of a novel heterozygous ALAS2 mutation in a young Chinese female with X-linked sideroblastic anemia.
    Ann Hematol. 2019 Dec 17. pii: 10.1007/s00277-019-03894.

  129. KAUNDAL R, Bhatia P, Jain A, Jain A, et al
    Randomized controlled trial of twice-daily versus alternate-day oral iron therapy in the treatment of iron-deficiency anemia.
    Ann Hematol. 2019 Dec 6. pii: 10.1007/s00277-019-03871.
    PubMed     Abstract available

  130. PARK S, Kelaidi C, Meunier M, Casadevall N, et al
    Correction to: The prognostic value of serum erythropoietin in patients with lower-risk myelodysplastic syndromes: a review of the literature and expert opinion.
    Ann Hematol. 2019 Dec 2. pii: 10.1007/s00277-019-03874.
    PubMed     Abstract available

  131. LAURENTINO MR, Parente Filho SLA, Parente LLC, da Silva Junior GB, et al
    Non-invasive urinary biomarkers of renal function in sickle cell disease: an overview.
    Ann Hematol. 2019;98:2653-2660.
    PubMed     Abstract available

  132. YINGJUN X, Yuhuan X, Yuchang C, Dongzhi L, et al
    CRISPR/Cas9 gene correction of HbH-CS thalassemia-induced pluripotent stem cells.
    Ann Hematol. 2019;98:2661-2671.
    PubMed     Abstract available

    November 2019
  133. LV X, Dong S, Lan F, Zhang B, et al
    Congenital dyserythropoietic anemia type I mimicking myelodysplasia syndrome with a novel CDAN1 mutation.
    Ann Hematol. 2019 Nov 23. pii: 10.1007/s00277-019-03848.

  134. SABUNCUOGLU S, Oztas Y, Yalcinkaya A, Unal S, et al
    The increased neopterin content in turkish pediatric patients with sickle cell anemia.
    Ann Hematol. 2019 Nov 23. pii: 10.1007/s00277-019-03817.
    PubMed     Abstract available

  135. OLATUNYA OS, Lanaro C, Longhini AL, Penteado CFF, et al
    Red blood cells microparticles are associated with hemolysis markers and may contribute to clinical events among sickle cell disease patients.
    Ann Hematol. 2019;98:2507-2521.
    PubMed     Abstract available

  136. MASY V, Sokal E, Ranguelov N, Brichard B, et al
    Fatal type B lactic acidosis in a patient with end-stage liver disease related to homozygous sickle cell disease.
    Ann Hematol. 2019;98:2627-2628.

    October 2019
  137. CHOQUE-QUISPE BM, Paz V, Gonzales GF
    Proportion of anemia attributable to iron deficiency in high-altitude infant populations.
    Ann Hematol. 2019 Oct 30. pii: 10.1007/s00277-019-03823.

  138. PARK S, Kelaidi C, Meunier M, Casadevall N, et al
    The prognostic value of serum erythropoietin in patients with lower-risk myelodysplastic syndromes: a review of the literature and expert opinion.
    Ann Hematol. 2019 Oct 25. pii: 10.1007/s00277-019-03799.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Anemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.